Selection of an ACE inhibitor in clinical practice
Currently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class effects, the drugs differ in pharmacokinetic charac...
| الحاوية / القاعدة: | Медицинский совет |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | مقال |
| اللغة: | الروسية |
| منشور في: |
Remedium Group LLC
2014-12-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.med-sovet.pro/jour/article/view/693 |
| الملخص: | Currently, ACE inhibitors are considered to be the gold standard in the treatment of cardiovascular diseases. They all have cardio-, vaso- and nephroprotective and positive metabolic effects; however, despite the large number of the so-called class effects, the drugs differ in pharmacokinetic characteristics which determine the difference in their clinical effects. The article is about choosing the optimal drug from the group of ACE inhibitors in clinical practice. |
|---|---|
| تدمد: | 2079-701X 2658-5790 |
